Abstract
Classifications of high-flow arteriovenous malformations (AVM5) have been published in the neurovascular literature and in the peripheral vascular literature. These two classification systems are essentially the same in their angioarchitecture analysis. We propose a new Yakes AVM classification system that includes all AVM angioarchitecture types and those that have not been previously reported in the world’s literature. This all-encompassing AVM classification system also recommends endovascular treatment strategies that are curative in that specific AVM classification type. Thus, by analyzing the angioarchitecture of the AVM, the practicing physician can then be guided to specific treatment strategies to permanently treat that AVM type. We describe AVMs as Yakes Type I, Yakes Type II, Yakes Type llla, Yakes Type IlIb, and Yakes Type IV.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Introduction
Vascular malformations constitute one of the most challenging entities in the history of medicine to diagnose and treat effectively by whatever endovascular or surgical approaches are employed. These congenital vascular lesions can involve any tissue in the body. The rarity of vascular malformations in the population compounds the problem of treating them. If a physician rarely encounters patients with vascular malformations, it is difficult to gain enough experience to optimally treat them and effectively eradicate them. High-flow arteriovenous malformations (AVMs) are extremely challenging to surgically extirpate or to endovascularly cure. The world’s literature certainly verifies the extreme challenges in the diagnosis and treatment of AVMs. The purpose of this chapter is to advance a new AVM Classification System that has proven therapeutic implications to effectively treat complex AVMs in any anatomical area. By employing the Yakes AVM Classification System, a physician is now able to accurately classify AVMs and determine specific endovascular treatment strategies to consistently treat AVMs, and patients can enjoy the long-term excellent outcomes. Defining the angioarchitecture of the high-flow AVM determines accurately the endovascular management strategy to best permanently ablate the AVM requiring treatment. Further, employing this new Yakes AVM Classification will lower complication rates in treating these complex congenital vascular pathologies.
Overview
The Houdart Classification of Intracranial Arteriovenous Fistulae and Malformations of high-flow lesions and the Cho-Do Classification of AVMs of the peripheral arterial circulation are strikingly similar despite their anatomic locational differences (CNS vs. peripheral vasculatures) [1–3]. Both authors also suggest similar therapeutic approaches based on their arteriographic classification. Houdart et al. Classification states the following types of AVMs: Type A as multiple arterial connections flow into a large aneurysmal vein with single outflow drainage, Type B as multiple microfistulae into an aneurysmal vein with single outflow vein, and Type C as multiple shunts between many arterioles and venules connected to each other. The Cho-Do et al. Classification based on “nidus morphology” provides the following types: Type I being arteriovenous larger fistulae with no more than three separate arteries shunt to the initial single venous outflow component, Type II as “arteriovenous smaller fistulae with multiple arterioles shunt to the initial part of a plexiform appearance” into a single venous component, Type IIIa as “arteriovenous fistulae with non-dilated fistulae with multiple fine shunts are present between arterioles and venules,” and Type IIIb being “arteriovenous fistulae with dilated fistulae with multiple shunts are present between arterioles and venules.”
Houdart Type A is the same as the Cho-Do Type I; Houdart Type B is the same as the combination of the Cho-Do types IIIa and IIIb. Therapeutic implications are also similar as well. The Houdart Type A and Type B and Cho-Do Types I and II proffer retrograde approaches to occlude the vein aneurysm outflow as being a potential for curative treatment of these AVM types. I proposed and illustrated the retrograde vein occlusion techniques for high-flow malformations first published and three cases illustrated in my manuscript published in 1990 [4]. Later, Jackson et al. published the retrograde vein approach in 1996 [5]. The Do group in Seoul, Korea (also the publishers of the Cho-Do AVM Classification), published the retrograde vein approach in 2008 after collaboration with our group demonstrated its efficacy to them in patients at their Seoul, Korea, Samsung Medical Center [6].
The Yakes AVM Classification System has some similarities to both classification systems and some stark differences. The Yakes AVM Classification System consists of the following: Type I is characterized by a direct arteriovenous fistula, a direct artery to vein connection (e.g., typified by pulmonary AVF and renal AVF). This angioarchitecture type is not described in the Houdart or Cho-Do Classification Systems. Type II is an AVM characterized by usually multiple inflow arteries into a “nidus” pattern with direct artery-arteriolar to vein-venular structures that may, or may not, be aneurysmal. Type IIIa consists of multiple arteries-arterioles into an enlarged aneurysmal vein with an enlarged single outflow vein. Type IIIb consists of multiple arteries-arterioles into an enlarged aneurysmal vein with multiple dilated outflow veins. Type IV comprises microfistulous innumerable arteriolar structures to innumerable venular connections that diffusely infiltrate a tissue (typified by ear AVMs that infiltrate the entire cartilage of the pinna). What is different in this lesion is that there are admixed among the innumerable fistulae capillary beds within the affected tissue. If the affected tissue only had AVFs, the tissue could not survive as capillary beds are required for tissue viability. No other AVM angioarchitecture has this duality [7]. This angioarchitecture is not described in the world’s literature.
Comparing Houdart’s CNS Classification and the Cho-Do Peripheral Vascular Classification to the Yakes Classification has some parallels, as has been described, but has several distinct differences.
Houdart Type A and Cho-Do Type I are the same and compare to the Yakes Type IIIa. Houdart Type B and Cho-Do Type II are the same and again are placed in the Yakes Type IIIa. Whether the arteriovenous (Type A/Type I) or arteriolar-venular connections (Type B/Type II) are present is not important as the same arterial physiology is present that the “nidus” being present in the vein wall itself, regardless of the size of AVF on the vein wall, as they are both treated endovascularly in the same way. Therefore, the AVF size is irrelevant. Further, even when larger AVF are present, microfistulae are also present as well admixed with the larger connections. It never is purely one microsize only or one macrosize only.
The Houdart Type C is the same as bundling Cho-Do Types IIIa (arteriovenous) and IIIb (arteriolar venular). This is similar to the Yakes Type II. Both authors do not explain in their classifications the Yakes Type IV. The angioarchitecture of arteriovenous and arteriolar-venular innumerable fistulae, totally infiltrating a particular tissue, is another vascular phenomenon that is present that is not explained by the Houdart nor the Cho-Do Classifications. Being that arteriographically these innumerable microfistulae are proven to infiltrate a tissue, one has to also consider that despite the innumerable microfistulae, there is interspersed within these abnormal fistulae vascularity that is normal with capillary beds that is nutrient to the infiltrated tissue as well, or the tissue itself would be devitalized and forced to necrose. Normal capillaries must be present admixed with the innumerable AVF in the infiltrated tissue, or it would not be viable and could not survive. Venous hypertension is usually the culprit in the injury that occurs in that infiltrated tissue, and this phenomenon as a vascular etiology for pathologic tissue changes was first elucidated by Jean Jacques Merland, M.D., and Marie Claire Riche, M.D [8]. Thus, the “normal” vascularity with capillary beds in the infiltrated tissue to allow it to exist is not discussed in the Houdart or in the Cho-Do Type Classifications or is the angioarchitecture characteristics described.
The Yakes Type I Classification is a direct AV macro-connection that is characteristic of pulmonary AVF and renal AVF, but can also occur in other tissues. This direct AV connection is not described in the Houdart Classification or in the Shin-Do Classification. The Yakes Type I AV connection can also be present and interspersed in complex AVMs as well (Fig. 33.1).
The Yakes Type II Classification possesses an angioarchitecture synonymous with the classical “nidus” pattern commonly seen in AVMs with multiple inflow arteries of varying sizes coursing toward a “nidus” (a complex tangle of vascular structures without any intervening capillaries and exiting from this “nidus” into multiple veins from this “nidus”). The Houdart Type C and the Cho-Do Type IIIa/Type IIIb most resemble this angioarchitecture pattern. Thus, the Yakes Type II and Yakes Type IV further define the Houdart Type C and Cho-Do Type IIIa/IIIb patterns (Fig. 33.2), much more specifically.
As an aside, the term “nidus” is rampant in the medical literature (AVM nidus, nidus of infection, etc.). Unfortunately, the initial author was only partially familiar with the Latin language. “Nidus” means “nest” in Latin, and indeed it does. However, “nidus” with the ending “us” denotes male gender. In the Latin language, the true term meaning “nest” is, in fact, “nidum.” The ending “um” denotes the neuter gender which a “nest” truly is. Thus, the original author accurately describing “nest-like” conglomeration of vascular structure was woefully inaccurate penning the words as “nidus” (masculine) instead of the true word “nidum” (neuter). Being rife in the literature for decades, there is no possibility of any correction of this term.
In summary, Yakes Type I is the simplest macro direct AV connection. Yakes Type II is the common “nidum” (nest-like) AV connection. Yakes Type IIIa has multiple AV connections (arterial and arteriolar into an aneurysmal vein: “nidum” is in the vein wall) with single outflow vein physiology (Fig. 33.3). Yakes Type IIIb has multiple arterial inflow connections (arterial and arteriolar) into an aneurysmal vein (“nidum” is in the vein wall) with multiple outflow veins that is more difficult to treat by retrograde vein approaches (Fig. 33.4).
Yakes Type IV angioarchitecture has innumerable micro-AV connections (with lowered vascular resistance) infiltrating an entire tissue but with concurrent normal vascular structures possessing nutrient capillary beds (with normal vascular resistance) to supply and drain the tissue that is diffusely infiltrated to allow this tissue to survive and not be devitalized. The postcapillary veins compete with AVF outflow veins that are arterialized (hypertensive) (Fig. 33.5) and cause the resultant nonhealing pathology. This entity has not been described in the world’s literature [9–22].
Therapeutic Implications of the Yakes Classification
Determining a classification system based on the AVM angioarchitecture is of little use without a practical application. For example, the Spetzler-Martin Brain AVM Classification is of importance to determine the surgical morbidity for treating brain AVMs [23]. The higher the Spetzler-Martin grade, the higher the morbidity. This allows the neurosurgeon to inform his/her patient accurately of the risks for treatment. The Schobinger AVM Classification for peripheral AVMs (non-neuro) is useful to quantify the degrees of symptomatology a patient possesses regardless of the AVM’s angioarchitecture. The Yakes Classification is utilized to determine endovascular approaches and embolic agents that will be successful to ablate these peripheral AVMs.
Embolic Agents Employed in the Yakes AVM Classification
Yakes Type I direct AV connections, as typically seen in pulmonary AVF and renal AVF, can be permanently ablated by occluding mechanical devices. Coils, Amplatzer plugs, occluders, detachable balloons, and the like are universally successful to cure Yakes Type I AVMs.
Yakes Type II AVMs with the “nidum” nest-like angioarchitecture can be permanently ablated with absolute ethanol from a superselective transcatheter/trans-microcatheter arterial approach. Also, a direct puncture into the artery(ies) supplying the AVM immediately proximal to the AVM “nidum” and distal to any parenchymal arterial branches and then a superselective ethanol injection can be employed to circumvent catheterization obstacles when a transcatheter/trans-microcatheter positioning to achieve the same position to deliver ethanol into the “nidum” is not possible. These two transarterial approaches allow ethanol to sclerose and permanently ablate the “nidum.” The “nidum” itself can be directly punctured, and ethanol (undiluted) can be injected to sclerose the “nidum” directly to effect cure in its multiple compartments as well.
Yakes Type IIIa AVMs (multiple inflow arteries into an aneurysmal vein with single enlarged vein outflow) and Yakes Type IIIb AVMs (multiple inflow arteries into an aneurysmal vein with multiple enlarged outflow veins) can be curatively treated by several endovascular approaches. The “nidum” in this type of angioarchitecture with an aneurysmal vein is in the vein wall itself. Superselective transarterial ethanol embolization distal to all parenchymal branches via transcatheter/trans-microcatheter and direct puncture endovascular approaches can be curative. An additional curative endovascular approach for Type IIIa AVMs is to coil embolize the aneurysmal vein itself with, or without, concurrent ethanol injection into the coils within the aneurysmal vein. This is also curative when the aneurysmal vein is totally and densely packed with coils. The aneurysmal vein can be endovascularly approached by direct 18 g needle puncture and by retrograde vein catheterization to achieve the same position within the aneurysmal vein to pack it with coils. The retrograde vein approach to curatively treat high-flow vascular lesions was first published and illustrated in 1990 by Yakes et al. The second article articulating the vein approach to AVM treatment was subsequently published in 1996 by Jackson et al. Cures were documented in these published patient series. Yakes et al. described cures of posttraumatic and congenital high-flow lesions, and Jackson et al. described cures of congenital AVMs by way of the retrograde vein approach in these publications [4, 5].
The Yakes Type IIIb AVMs (aneurysmal vein with enlarged multiple outflow veins) can be cured by transarterial transcatheter ethanol embolization and by direct puncture and retrograde vein coiling techniques. However, the aneurysmal vein portion and the immediate adjacent segments of each outflow vein must also be packed with coils completely to achieve cure. Yakes Type IIIb AVMs are more challenging to cure than the Yakes Type IIIa AVMs due to the more complex vein outflow morphology.
Yakes Type IV AVMs presented a unique challenge to determine curative endovascular treatment. AVMs, by definition, are direct AV connections without an intervening capillary bed (Yakes Types I–IV). Thus, superselective catheter and direct puncture needle positioning distal to ALL branches supplying parenchyma and immediately proximal to the AVM itself will obviate tissue necrosis being that the capillary beds are not embolized and only the abnormal AV connections are sclerosed. However, Yakes Type IV AVMs infiltrate an entire tissue, thus termed by the authors as an “infiltrative” form of AVM. Being that the “infiltrated” tissue (e.g., auricular AVMs) is viable proves that capillary beds are undoubtedly interspersed along with the innumerable microfistulae throughout the involved tissue as well. Injection of ethanol by transcatheter/trans-microcatheter and direct puncture approaches will sclerose the innumerable microfistulae, but also would flood the capillary beds with ethanol devitalizing that infiltrated tissue. Necrosis of that tissue would then ensue with occlusion of the capillary beds. Thus, Yakes Type IV AVMs were a conundrum to treat with endovascular approaches. Polymerizing agents would also occlude AVFs, but also capillary beds causing a massive necrosis.
Thinking through this conundrum, one could rightly conclude that the only option is total surgical resection of that entire tissue as the only treatment option. After further reflection, an endovascular option for curative treatment, not palliative treatment, was considered a possibility. Capillary beds have normal peripheral resistance which is a somewhat restrictive vascular flow pattern from artery to capillary to veins. AVMs/AVF has abnormally lowered peripheral vascular resistance with rapid stunting into arterialized veins. The arterialized AVM outflow veins are hypertensive. In AVMS, the normotensive post-capillary venules compete with the arterialized hypertensive post-AVF veins/venules for out-flow of the blood. This then further restricts normal vein outflow, which in turn increases the systemic vascular resistance (SVR) of the normal arterioles immediately proximal to the capillary beds, further restricting arteriolar inflow to the capillary beds. The increased SVR into the capillaries coupled with abnormally low-resistance shunting into the admixed innumerable AVF allows preferential flow into the AVFs.
Mixing nonionic contrast with absolute ethanol changes the viscosity and specific gravity of ethanol in this mixture. Being “thickened” and diluted, this allows for preferential flow to the AVFs and further restricts flow into the capillaries. Despite being 50 % diluted with contrast, the ethanol can still effectively sclerose the innumerable microfistulae, due to the small luminal diameters. This combination of preferential flow into the innumerable AVFs, the increased SVR into the capillaries restricting flow, and the increased viscosity and changing the specific gravity of the contrast and ethanol 50 % mixture all work to spare the capillaries and sclerose the innumerable AVFs. Using pure ethanol would not have this capillary sparing effect, and the AVFs and capillaries would both be sclerosed and occluded. This does cure the AVFs, but devitalizes the tissue itself with occlusion of the capillaries. Use of various polymerizing embolic occlusive agents (NBCA, Onyx) would also cause the same devitalization of the tissues with occlusion of the capillaries. Particulate embolic agents (PVA, Contour Embolic, Embospheres, etc.) cannot permanently occlude the AVFs and will make the capillaries ischemic with the proximal occlusion in the inflow arterioles, but will not devitalize the tissues.
Summary
-
Yakes Type I: Can be permanently occluded, with mechanical devices such as coils, fibered coils, Amplatzer plugs, and other occluding devices.
-
Yakes Type II: Can be permanently occluded with undiluted absolute ethanol. At times slowing the arterial inflow in the “nidum” with occlusion balloons, tourniquets, and blood pressure cuffs does allow for less ethanol to be used to treat the AVM compartments. Direct puncture techniques into the inflow artery or AVM “nidum” allow ethanol to embolize the AVM as well.
-
Yakes Type IIIa: Can be permanently occluded with transarterial embolizations with ethanol of the “nidum” the same way as in the Yakes Type II AVM. They can also be permanently occluded by dense coil packing of the vein aneurysm with or without ethanol embolization. This can be accomplished via direct puncture of the vein aneurysm or by retrograde vein catheterization of the vein aneurysm.
-
Yakes Type IIIb: Can be permanently occluded via transarterial approach as in Yakes Type II AVMs. They can be permanently occluded by treating the vein aneurysm and the multiple aneurismal outflow veins by coil embolization.
-
Yakes Type IV: Can be permanently occluded via transarterial superselective 50 % mixture of nonionic contrast and ethanol that treats the micro-AVFs and spares the higher-resistance capillaries. Direct puncture with 23 gauge needles into the microfistulous AV connection itself (thus bypassing any capillaries) with pure undiluted ethanol injections is also curative.
References
Houdart E, Gobin YP, Casasco A, Aymard A, Herbreteau D, Merland JJ (1993) A proposed angiographic classification of intracranial arteriovenous fistulae and malformations. Neuroradiol ogy 35:381–385
Cho SK, Do YS, Shin SW, Kim DI, Kim YW, Park KB et al (2006) Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther 13:527–538
Park KB, Do YS, Kim DI, Kim YK, Shin BS, Park HS et al (2012) Predictive factors for response of peripheral arteriovenous malformations to embolization therapy: analysis of clinical data and imaging findings. J Vasc Interv Radiol 23:1478–1486
Yakes WF, Luethke JM, Merland JJ, Rak KM, Slater DD, Hollis HW, Parker SH, Casasco A, Aymard A, Hodes J, Hopper KD, Stavros AT, Carter TE (1990) Ethanol embolization of arteriovenous fistulas: a primary mode of therapy. J Vasc Interv Radiol 1:89–96
Jackson JE, Mansfield AO, Allison DJ (1996) Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Intervent Radiol 19:323–328
Cho SK, Do YS, Kim DI, Kim YK, Shin SW, Park KB, Ko JS, Lee AR, Choo SW, Choo IW (2008) Peripheral arteriovenous malformations with a dominant outflow vein: results of ethanol embolization. Korean J Radiol 9:258–267
Yakes WF, Yakes AM (2014) Arteriovenous malformations. The Yakes classification and its therapeutic implications. Egyptian Journal of Vascular & Endovascular Surgery 10:19–23
Merland JJ, Riche MC, Chiras J (1980) Intraspinal extramedullary arteriovenous fistula draining into medullary veins. J Neuroradiol 7:271–320
Enjolras O, Wassef M, Chapot R (2007) Introduction ISSVA classification: color atlas of vascular tumors and vascular malformations, 1st edn. Cambridge University Press, New York, pp 1–12
Legiehu GM, Heran MKS (2006) Classification, diagnosis and interventional radiologic management of vascular malformations. Orthop Clin North Am 37:435–474
Puig S, Aref H, Chigot V, Bonin AB, Bruenelle F (2003) Classifications of venous malformations in children and implications for sclerotherapy. Pediatr Radiol 33(2):99–103
Lee BB, Laredo J, Lee TS, Huh S, Neville R (2007) Terminology and classification of congenital vascular malformations. Phlebology 22:249–252
Do YS, Yakes WF, Shin SW, Lee BB, Kim DI, Liu WC, Shin BS, Kim DK, Choo SW, Choo IW (2005) Ethanol embolization of arteriovenous malformations: interim results. Radiology 235:674–682
Yakes WFJ (2008) Endovascular management of high flow arteriovenous malformations. Chin J Stomatol 43:327–332
Yakes WF, Pevsner P, Reed M (1986) Serial embolizations of an extremity arteriovenous malformation with alcohol via direct percutaneous puncture. Am J Roentgenol 146:1038–1040
Vinson AM, Rohrer DB, Wilcox CW et al (1988) Absolute ethanol embolization for peripheral arteriovenous malformation: report of 2 cures. South Med J 81:1052–1055
Yakes WF, Haas DK, Parker SH, Gibson MD et al (1989) Symptomatic vascular malformations: ethanol and embolotherapy. Radiology 170:1059–1066
Yakes WF, Parker SH, Gibson MD et al (1989) Alcohol embolotherapy of vascular malformations. Semin Intervent Radiol 6:146–161
Mourao GS, Hodes JE, Gobin YP, Casasco A, Aymard A, Merland JJ (1991) Curative treatment of scalp arteriovenous fistulas by direct puncture and embolization with absolute alcohol. J Neurosurg 75:634–637
Vogelzang RL, Yakes WF (1997) Vascular malformations: effective treatment with absolute ethanol. In: Pearce WH, Yao JST (eds) Arterial surgery: management of challenging problems. Appleton and Lange Publishers, Norwalk, Connecticut, pp 553–560
Yakes WF, Rossi P, Odink H (1996) Arteriovenous malformation management: how I do it. Cardiovasc Intervent Radiol 19:65–71
Doppman JL, Pevsner P (1983) Embolization of arteriovenous malformations by direct percutaneous puncture. AJR Am J Roentgenol 140:773–778
Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65:476–483
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
Yakes, W.F., Yakes, A.M. (2015). Classification of Arteriovenous Malformation and Therapeutic Implication. In: Mattassi, R., Loose, D., Vaghi, M. (eds) Hemangiomas and Vascular Malformations. Springer, Milano. https://doi.org/10.1007/978-88-470-5673-2_33
Download citation
DOI: https://doi.org/10.1007/978-88-470-5673-2_33
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5672-5
Online ISBN: 978-88-470-5673-2
eBook Packages: MedicineMedicine (R0)